• Joseph Mazza MD, MACP

  • Emeritus Researcher


    • Clinical Research Center
    • 1000 North Oak Avenue 1R5 Marshfield, WI 54449
    • (715) 389-7643

Education


1965 to 1969:
Internal Medicine - Hematology and Coagulation, Mayo Clinic, Rochester
1962 to 1963:
Cook County Hospital, Chicago
1962:
MD, Loyola University, Chicago
1958:
BS, Kings College, Wilkes-Barre

Work Experience


2007 to Present:
Emeritus Senior Research Scientist, Marshfield Clinic Research Institute, a division of Marshfield Clinic, Inc., Marshfield
1988 to Present:
Clinical Professor of Medicine, University of Wisconsin School of Medicine, Madison
1996 to 2012:
Director's Advisory Panel, Marshfield Medical Research & Education Foundation, Marshfield
1972 to 2010:
Staff Appointment in Internal Medicine & Hematology, University of Wisconsin School of Medicine, Madison
1970 to 2007:
Oncologist/Hematologist, Marshfield Clinic, 1000 North Oak Avenue, Marshfield
1992 to 2004:
Governor, Wisconsin American College of Physicians
1996 to 2002:
Director of Medicine/Pediatrics Residency Program, Marshfield Clinic & St. Joseph's Hospital, Marshfield
1993 to 2000:
Associate Dean, University of Wisconsin, Marshfield Campus, Marshfield
1992 to 1999:
Director of Medical Education, Marshfield Clinic, Marshfield
1985 to 1993:
Board of Trustees, Marshfield Medical Research & Education Foundation, Marshfield
1990 to 1992:
Vice President, Marshfield Medical Research & Education Foundation, Marshfield
1989 to 1992:
Chairman - Residency Recruiting Committee, Marshfield Clinic & St. Joseph's Hospital, Marshfield
1979 to 1992:
Chairman - Residency Review Committee, Marshfield Clinic & St. Joseph's Hospital, Marshfield
1975 to 1991:
Assistant Director of Internal Medicine Residency Program, Marshfield Clinic, Marshfield
1982 to 1986:
Head, Section of Hematology, Marshfield Clinic, Marshfield
1978 to 1980:
Area 12 Medical Director, Wisconsin Division of the American Cancer Society
1975 to 1978:
Secretary - Department of Internal Medicine, Marshfield Clinic, Marshfield
1963 to 1965:
U.S. Navy Lt., 2nd Marine Air Wing, Cherry Point

Board Certifications


1971 to Present:
Recertified, American Board of Internal Medicine
1974 to Present:
Certified in Hematology, American Board of Internal Medicine

Honors & Awards


1979:
1980, 1981, 1990, 1994 1996: University of Wisconsin Alumni Teachers Award
1981:
George Magnin Teaching Award, Marshfield Medical Center
1991:
Erwin R. Schmidt Award, Medical Society of North America
1992:
Meritorious Service Award, State Medical Society of Wisconsin
1994:
Distinguished Internist of the Year, Wisconsin Society of Internal Medicine
1998:
ACP Laureate Award-Wisconsin Chapter
1999:
Distinguished Service Award for Continuing Medical Education Programs, Wisconsin State Medical Society
1999:
Outstanding Alumnus for Professional Achievements in BioSciences, King's College Alumni Association
1999:
Dedicated Service for my Contributions in Medical Education to the University of Wisconsin School of Medicine
2005:
Gwen D. Sebold Fellowship for Outstanding Research Award

Statement


Dr. Mazza is a Hematologist/Oncologist with a deep interest in Immunology. I joined the Marshfield Clinic in 1970 and practiced my specialty for 36 years before joining the Research Foundation. I am a Master in the American College of Physicians, served as Director of Medical Education, Assistant Director of the Internal Medicine residency program, and Director of the Med-Peds residency program at Marshfield Clinic. Dr. Mazza is on four editorial boards of medical journals, has published more than 140 scientific articles in peer review journals, several book chapters and is the editor of The Manual of Clinical Hematology. Other books authored include A Fifty Year History of Marshfield Clinic Research Foundation and The History of the National Farm Medicine Center. Dr. Mazza and his wife, Ginny, have four children and they live in Marshfield with their dog Lucy.

Professional Societies


1972 to Present:
American Medical Association
1972 to Present:
American Society of Internal Medicine
1972 to Present:
Wisconsin Society of Internal Medicine
1972 to Present:
Wood County Medical Society
1974 to Present:
Fellow, American College of Physicians
1974 to Present:
Faculty in Clinical Medicine, UW
1975 to Present:
American Society of Hematology
1975 to Present:
New York Academy of Sciences
1978 to Present:
Executive Board, Upper Great Lakes Hemophilia Society
1979 to Present:
American Association for the Advancement of Science
1984 to Present:
American Society of Clinical Oncology
2000 to Present:
Master, American College of Physicians

Committees


1991 to 1995:
Annals of Internal Medicine, Editorial Board Member
2000 to Present:
Wisconsin Medical Journal, Editorial Board Member
2004 to Present:
Journal of Agromedicine, Editorial Board Member
2005 to Present:
Journal of Clinical Medicine and Research, Editorial Board Member

Select Publications


  • Mazza JJ, Bowie EJ, Hagedorn AB, Didisheim P, Taswell HF, Peterson LF, Owen CA. (1970 March). Antihemophilic factor 8 in hemophilia. Use of concentrates to permit major surgery. JAMA. 211(11):1818-1823.
    PubMed ID: 5467109
  • Hansotia PL, Mazza JJ. (1973). Myasthenia gravis with systemic lupus. NEUROLOGY. 23 :436.
  • Pearson B, Mazza JJ. (1975 July). Gardner-Diamond syndrome with multiple glomus tumors. Arch Dermatol. 111(7):893-895.
    PubMed ID: 167663
  • Mazza JJ, Magnin GE. (1975 November). Severe thrombocytopenia in infectious mononucleosis. Report of two cases and review of the literature. Wis Med J. 74(11):124-127.
    PubMed ID: 1199133
  • Hansotia PL, Mazza JJ, Gatlin PF. (1975 July). Diphenylhydantoin and fragility of erythrocytes in normal subjects and in patients with hereditary spherocytic anemia. Am J Clin Pathol. 64(1):75-79.
    PubMed ID: 1155377
  • Brosseau JD, Mazza JJ. (1977 November). Group A streptococcal sepsis and arthritis. Origin from an intrauterine device. JAMA. 238(20):2178.
    PubMed ID: 335092
  • Friedenberg WR, West M, Miech DJ, Mazza JJ. (1978 April). Atypical purpura fulminans with benign monoclonal gammopathy. Arch Dermatol. 114(4):578-580.
    PubMed ID: 646371
  • Mazza JJ. (1979 October). The granulomatous reaction--its role in the host response. Wis Med J. 78(10):34-37.
    PubMed ID: 524904
  • Sautter RD, Larson DE, Bhattacharyya SK, Chen HM, Treuhaft PS, Milbauer JP,...Wenzel FJ [including Mazza JJ, Emanuel DA, Myers WO, Ray JF, Plotka ED, Nycz G.] (1979 February). The limited utility of fibrinogen I 125 leg scanning. Arch Intern Med. 139(2):148-153.
    PubMed ID: 434967
  • Mazza JJ, Kryda MJ. (1980 June). Tetracycline-induced hemolytic anemia. J Am Acad Dermatol. 2(6):506-508.
    PubMed ID: 7400406
  • Mazza JJ, Gatlin PF, Marx JJ. (1980). Inhibition of platelet aggregation with histamine. Am J Hematol. 8(3):257-263.
    PubMed ID: 6251719
  • Hines JD, Mazza JJ, Oken MM, Keller AM, Glick JH. (1981). High dose Ara-C and mAMSA in the treatment of relapse and refractory acute nonlymphocytic leukemia (ANLL). BLOOD. 58(Suppl 1):142a.
  • Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR, Glick JH. (1982). High dose cytosine arabinoside (Ara-C) and mAMSA is effective therapy in relapsed acute nonlymphocytic leukemia (ANLL). Third International Symposium on Therapy of Acute Leukemia. :342.
  • Conterato JP, Friedenberg WR, Mazza JJ, Gatlin PF, Gehlsen JA, Schloesser LL. (1983). Improved treatment of acute nonlymphocytic leukemia in a community hospital. The Marshfield Clinic/St. Joseph's Hospital experience 1974-1981. Proc Am Soc Clin Oncol. 2 :171.
  • Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR. (1983). High dose cytosine arabinoside (Ara-C) and mAMSA in relapsed acute nonlymphocytic leukemia (ANLL). Proc Am Soc Clin Oncol. 2 :173.
  • Kahn SB, Begg CB, Mazza JJ, Glick JH. (1983). Full dose daunorubicin (D), cytosine arabinoside (A) and thioguanine (T) (F-DAT) versus attenuated DAT (AT-DAT) in the treatment of ANLL in the elderly. Results of a randomized ECOG trial. Proc Am Soc Clin Oncol. 2 :178.
  • Banerjee TK, Ousley JL, Mazza JJ, Gehlsen JA, Tiffany E. (1983). Vindesine response in a phase II trial in malignant tumors. Proc Am Soc Clin Oncol. 2 :225.
  • Hines JD, Mazza JJ, Oken MM, Keller AM, Adelstein DJ, Bennett JM, O'Connell MJ. (1983). High dose cytosine arabinoside (HDARAC) and mAMSA induction and consolidation in acute nonlymphocytic leukemia (ANLL). BLOOD. 62(Suppl 1):203a.
  • Friedenberg WR, Gatlin PF, Mazza JJ, Hoehn JL, Beltaos E, Greenlaw RH,...Schloesser LL. (1983). The treatment of Hodgkin's disease at a non-university institution. BLOOD. 62(Suppl 1):212a.
  • Mazza JJ, Ries PM, Friedenberg WR. (1983 June). Serum ferritin as a means of assessing body iron stores. Wis Med J. 82(6):27-30.
    PubMed ID: 6613156
  • Sautter RD, Koch EL, Myers WO, Ray JF, Mazza JJ, Larson DE,...Plotka ED [including Milbauer JP.] (1983 November). Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement. JAMA. 250(19):2649-2654.
    PubMed ID: 6355542
  • Mazza JJ. (1983 September). Hematologic problems in the elderly. Wis Med J. 82(9):13-16.
    PubMed ID: 6649671
  • Conterato JP, Friedenberg WR, Mazza JJ, Gatlin PF, Gehlsen JA, Schloesser LL. (1983 December). Improved treatment of acute nonlymphocytic leukemia in a community hospital--The Marshfield Clinic/St Joseph's Hospital; experience 1974-1981. Wis Med J. 82(12):17-21.
    PubMed ID: 6582689
  • Mazza JJ, Friedenberg WR, Hocking WG, Gehlsen JA, Schloesser LL. (1983). Treatment of acute leukemia in adults. Marshfield Clinic Bulletin. :111-122.
  • Hines JD, Mazza JJ, Oken MM, Keller AM, Adelstein DJ, Bennett JM, O'Connell MJ. (1984). High dose Ara-C and mAMSA in the treatment of relapse and refractory acute nonlymphocytic leukemia (ANLL). Proc Am Soc Oncol. 3 :189.
  • Cassileth PA, Begg CB, Bennett JM, Burkart P, Keller AM, Knospe W,...O'Connell MJ [including Mazza JJ.] (1984). Intensive consolidation therapy with high dose cytosine arabinoside (Ara-C) and amsacrine (AMSA) in adults with acute nonlymphocytic leukemia (ANLL). Proc Am Soc Clin Oncol. 3 :194.
  • Hines JD, Oken MM, Mazza JJ, Keller AM, Streeter RR, Glick JH. (1984 June). High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia. J Clin Oncol. 2(6):545-549.
    PubMed ID: 6233399
  • Friedenberg WR, Gatlin PF, Mazza JJ, Beltaos E, Hoehn JL, Pierce WE,...Schloesser LL. (1984 March). Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease. J Lab Clin Med. 103(3):489-490.
    PubMed ID: 6699469
  • Kahn SB, Begg CB, Mazza JJ, Bennett JM, Bonner H, Glick JH. (1984 August). Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol. 2(8):865-870.
    PubMed ID: 6379120
  • Mazza JJ. (1985). Chronic lymphocytic leukemia. In: Messerli FH (Ed.), Current Clinical Practice (pp. 333-335). Philadelphia, PA: Saunders.
  • Mazza JJ. (1985). Chronic myelogenous leukemia. In: Messerli FH (Ed.), Current Clinical Practice (pp. 335-336). Philadelphia, PA: Saunders.
  • Hines JD, Mazza JJ, Oken MM, Bennett JM, Adelstein DJ, Keller AM, O'Connell MJ. (1985 June). High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group. Semin Oncol. 12(2 Suppl 3):117-119.
    PubMed ID: 3839318
  • Spiers AS, Davis MP, Levine M, Mangan KF, Mazza JJ, Neu LT,...Wiltsie JC. (1985 June). T-cell chronic lymphocytic leukaemia: anomalous cell markers, variable morphology, and marked responsiveness to pentostatin (2'-deoxycoformycin). Scand J Haematol. 34(1):57-67.
    PubMed ID: 2578689
  • Friedenberg WR, Mazza JJ, Hines JD. (1986). Treatment of acute megakaryocytic leukemia. Ann Intern Med (letter). 104 :280-281.
  • Mazza JJ, Friedenberg WR. (1986). Clinical cancer: progress in acute leukemia. Wis Med J. 85 :26-27.
  • Linn BJ, Mazza JJ, Friedenberg WR. (1986 May). Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis. Postgrad Med. 79(6):171-180.
    PubMed ID: 3703754
  • Friedenberg WR, Dirks P, Beltaos E, Mazza JJ, Hoehn JL, Greenlaw RH,...Schloesser LL [including Russ HH.] (1986 January). Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979). CANCER. 57(1):12-17.
    PubMed ID: 3753582
  • Cassileth PA, Andersen J, Tsung L, Hoagland HC, Mazza JJ, Bennett JM,...Eastern Cooperative Oncology Group. (1987). Systemic high-dose cytarabine (HDARAC) provides effective central nervous system (CNS) prophylaxis in adult acute lymphocytic leukemia (ALL). BLOOD. 70 :225a.
  • Mazza JJ, Rushing DA, Friedenberg WR, Banerjee TK, Gehlsen JA. (1987). Myelodysplasia and acute leukemia following dibromodulcitol therapy. BLOOD. 70 :204a.
  • Cassileth PA, Begg CB, Silber R, Spiers AS, Burkart P, Scharfman W,...Oken MM [including Mazza JJ.] (1987 February). Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia. Cancer Treat Rep. 71(2):137-140.
    PubMed ID: 3802110
  • Hines JD, Mazza JJ, Oken MM, Adelstein DJ, Keller AM, Bennett JM, O'Connell MJ. (1987 June). Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia. Semin Oncol. 2(Suppl 1):37-39.
    PubMed ID: 3296207
  • Cassileth PA, Andersen J, Hoagland J, Mazza JJ, Bennett JM, O'Connell MJ. (1987). Efficacy of high dose cytarabine (HDARAC) in initial therapy of adult acute lymphocytic leukemia (ALL). Proceedings of the American Society of Clinical Oncologists. 6 :158.
  • Friedenberg WR, Mazza JJ. (1987). Treatment of advanced lymphomas. Marshfield Clinic Bulletin. :35-46.
  • Mazza JJ. (1988). In: Mazza JJ (Ed.), Manual of Clinical Hematology Boston, MA: Little, Brown and Company.
  • Mazza JJ. (1988). Anemia of chronic disease. In: Mazza JJ (Ed.), Manual of Clinical Hematology (pp. 34-41). Boston, MA: Little, Brown & Co..
  • Mazza JJ. (1988). Chronic leukemia. In: Mazza JJ (Ed.), Manual of Clinical Hematology (pp. 193-200). Boston, MA: Little, Brown & Co..
  • Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave PB,...O'Connell MJ. (1988 April). Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J Clin Oncol. 6(4):583-587.
    PubMed ID: 3282032
  • Kay NE, Oken MM, Mazza JJ, Bradley EC. (1988). Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2. Nouv Rev Fr Hematol. 30(5-6):475-478.
    PubMed ID: 3265509
  • Mazza JJ, Mueller-Rizner NJ, Roberts RC. (1989). Multiple generations of inherited antithrombin III (AT-III) deficiency. BLOOD. 74(Suppl 1):393a.
  • Mazza JJ, Reding DJ. (1989). Hematopoietic growth factors: current use and future potential. Southern J Med.
  • Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave PB,...O'Connell MJ. (1990). Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group. Haematol Blood Transfus. 33 :267-70.
    PubMed ID: 2182420
  • Rowe JM, Mazza JJ, Hines JD, Cassileth PA, Oken MM, Bennett JM, Andersen J. (1990). Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia. Haematol Blood Transfus. 33 :326-329.
    PubMed ID: 2182427
  • Mazza JJ, Mueller-Rizner NJ, Roberts RC. (1991 December). Antithrombin-III (AT-III) deficiency spanning four generations. Thromb Haemost. 66(6):737-738.
    PubMed ID: 1796421
  • Raphael B, Andersen JW, Silber R, Oken MM, Moore D, Bennett JM,...Mazza JJ. (1991 May). Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J Clin Oncol. 9(5):770-776.
    PubMed ID: 2016618
  • Mazza JJ, Reding DJ, Plank GS. (1992). Growth factors: a promising future. Postgraduate Med. :91.
  • Mazza JJ, Reding DJ, Plank GS. (1992 June). Hematopoietic growth factors. A promising future for use in bone marrow dysfunction. Postgrad Med. 91(8):299-302, 305, 309 passim.
    PubMed ID: 1603758
  • Cassileth PA, Andersen JW, Bennett JM, Hoagland HC, Mazza JJ, O'Connell MJ,...Wiernik PH. (1992). Adult acute lymphocytic leukemia: the Eastern Cooperative Oncology Group experience. Leukemia. 6(Suppl 2):178-181.
    PubMed ID: 1578927
  • Cassileth PA, Lynch E, Hines JD, Oken MM, Mazza JJ, Bennett JM,...O'Connell MJ. (1992 April). Varying intensity of postremission therapy in acute myeloid leukemia. BLOOD. 79(8):1924-1930.
    PubMed ID: 1562720
  • Mazza JJ, Mueller-Rizner NJ, Roberts RC. (1992). Antithrombin-III (AT-III) deficiency spanning four generations. Thromb Haemost (letter). 67 :490.
  • Cassileth PA, Andersen JW, Bennett JM, Harrington DP, Hines JD, Lazarus HM,...Paietta E [including Mazza JJ.] (1992). Escalating the intensity of post-remission therapy improves the outcome in acute myeloid leukemia: the ECOG experience. The Eastern Cooperative Oncology Group. Leukemia. 6(Suppl 2):116-119.
    PubMed ID: 1578910
  • Rowe JM, Andersen J, Mazza JJ, Paietta E, Bennett JM, Hayes A,...Wiernik PH. (1993 December). Phase III randomized placebo-controlled study of GM-CSF in adult patient (55-70 years) with AML. A study of the Eastern Cooperative Oncology Group (ECOG). American Society of Hematology Meeting Proceedings.
  • Rezkalla SH, Mazza JJ, Kloner RA., Tillema VB, Chang S. (1993 July). Effects of cocaine on human platelets in healthy subjects. Am J Cardiol. 72(2):243-246.
    PubMed ID: 8328397
  • Mazza JJ. (1993 May). Pancreatic and islet transplantation for diabetes. N Engl J Med. 328(20):1496-1497.
    PubMed ID: 8479477
  • Gordon LI, Andersen J, Gregory S, Mazza JJ, Chervenick P, Hahn RG, O'Connell MJ. (1993 January). A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the Eastern Cooperative Oncology Group. CANCER. 71(2):464-470.
    PubMed ID: 8422640
  • Mazza JJ, Lee BC, Gunderson PD, Stueland DT. (1994). Educational needs assessment of rural health care practitioners. Ann Agr Environ Med. 1 :285.
  • Rowe JM, Andersen JW, Mazza JJ. (1994). Treatment of relapsed and refractory AML with mitoxantrone and etoposide. A study of the Eastern Cooperative Oncology Group. Acute Leukemias IV. :235-238.
  • Prevost M, Turenne Y, Moote DW, Mazza JJ, Clermont A, PetitClerc C, Danzig MR. (1994 January). Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther. 16(1):50-56.
    PubMed ID: 7911402
  • Mazza JJ. (1994 April). A Library for Internists VIII. Recommendations from the American College of Physicians. Ann Intern Med. 120(8):699-720.
    PubMed ID: 7695157
  • Mazza JJ. (1995). In: Mazza JJ (Ed.), Manual of Clinical Hematology (2nd ed.). Boston, MA: Little, Brown and Company.
  • Mazza JJ. (1995). Hematopoiesis and hematopoietic growth factors. In: Mazza JJ (Ed.), Manual of Clinical Hematology (2nd ed.). (pp. 1-16). Boston, MA: Little, Brown & Co..
  • Mazza JJ. (1995). Anemia of chronic disease. In: Mazza JJ (Ed.), Manual of Clinical Hematology (2nd ed.). (pp. 53-60). Boston, MA: Little, Brown & Co..
  • Mazza JJ. (1995). Chronic myelogenous leukemia. Manual of Clinical Hematology (2nd ed.). (pp. 242-250). Boston, MA: Little, Brown & Co..
  • Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA,...Wiernik PH. (1995 July). A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). BLOOD. 86(2):457-462.
    PubMed ID: 7605984
  • Mazza JJ, Hines JD, Anderson JW, Neiman RS, Mann R, Oken MM, O'Connell MJ. (1995 July). Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma. Leuk Lymphoma. 18(3-4):289-296.
    PubMed ID: 8535195
  • Friedenberg WR, Miller HJ, Marx JJ, Schloesser LL, Reding DJ, Mazza JJ,...Cassileth PA [including Hocking WG, Mercier RJ.] (1995 April). The treatment of older adult patients with acute myeloid leukemia by triple infusion chemotherapy. Am J Clin Oncol. 18(2):105-110.
    PubMed ID: 7900701
  • Chua J, Lee JDouglas, Mazza JJ, Remeika L, Shaw GR. (1996 September). Recurrent infections in a 74-year-old man with neutropenia and large granular lymphocytosis. Proceedings of the IDSA 34th Annual Meeting.
  • Mazza JJ, Leong T, Rowe JM, Wiernik PH, Cassileth PA. (1996 January). Treatment of adult patients with acute lymphocytic leukemia in relapse. Leuk Lymphoma. 20(3-4):317-319.
    PubMed ID: 8624473
  • Rowe JM, Rubin A, Mazza JJ, Bennett JM, Paietta E, Anderson JW,...Wiernik PH. (1996). Incidence of infections in adult patients (>55) with acute myeloid leukemia treated with yeast-derived GM-CSF (sargramostim). Results of a double-blind prospective study by the Eastern Cooperative Oncology Group. Acute Leukemias V.
  • Mazza JJ. (1997 August). Marshfield Clinic'c role in primary care and rural health in Wisconsin. Wis Med J. 96(8):12-13.
    PubMed ID: 9283257
  • Mazza JJ, Lee BC, Gunderson PD, Stueland DT. (1997). Rural health care providers' educational needs related to agricultural exposures. J Agr Safety Health. 3 :207-215.
  • Friedenberg WR, Spencer SK, Musser CJ, Hogan TF, Rodvold KA, Rushing DA,...Marx JJ [including Mazza JJ, Tewksbury DA.] (1999 June). Multi-drug resistance in chronic lymphocytic leukemia. Leuk Lymphoma. 34(1-2):171-178.
    PubMed ID: 10350346
  • Yale SH, Mazza JJ. (2000 November). Anion gap acidosis associated with acetaminophen. Ann Intern Med. 133(9):752-753.
    PubMed ID: 11074927
  • Mazza JJ, Birhiray RE, Clouse LH, Friedenberg WR, Hocking WG, Mercier RJ, Reding DJ. (2001 December). Five-year single institution study of acute adult leukemia. 43rd ASH Annual Meeting.
  • Mazza JJ. (2001 June). Ethical principles for everyone. Ann Intern Med. 134(12):1151; author reply 1152-1153.
    PubMed ID: 11412062
  • Holmes SJ, Yale SH, Mazza JJ. (2001 November). Rectus sheath hematoma as a cause of acute abdominal pain. Am Fam Physician. 64(10):1681-1682.
    PubMed ID: 11759076
  • Yale SH, Mazza JJ. (2001). Approach to diagnosing lower extremity edema. Compr Ther. 27(3):242-252.
    PubMed ID: 11569326
  • Mazza JJ. (2002). In: Mazza JJ (Ed.), Manual of Clinical Hematology (3rd ed.). Baltimore, MD: Lippincott.
  • Mazza JJ. (2002). Hematopoiesis and hematopoietic growth factors. In: Mazza JJ (Ed.), Manual of Clinical Hematology (3rd ed.). (pp. 1-16). Baltimore, MD: Lippincott.
  • Mazza JJ. (2002). Anemia of chronic disease. In: Mazza JJ (Ed.), Manual of Clinical Hematology (3rd ed.). (pp. 54-61). Baltimore, MD: Lippincott.
  • Mazza JJ. (2002). Chronic myelogenous leukemia. In: Mazza JJ (Ed.), Manual of Clinical Hematology (3rd ed.). (pp. 239-246). Baltimore, MD: Lippincott.
  • Mazza JJ. (2002). Cutaneous T-cell lymphomas. In: Mazza JJ (Ed.), Manual of Clinical Hematology (3rd ed.). (pp. 335-354). Baltimore, MD: Lippincott.
  • Shah MC, Friedenberg WR, Mazza JJ, Montgomery R. (2002). Conversion of type 2 von Willebrand disease type 1 von Willebrand disease associated with repair of valvular heart disease. Guthrie J. 71 :6-9.
  • Yale SH, Mazza JJ, Stone GE. (2002 May). Photo quiz. Swollen tonsil. Am Fam Physician. 65(9):1877-1878.
    PubMed ID: 12018811
  • Salzman SA, Mazza JJ, Burmester JK. (2002 March). Regulation of colony-stimulating factor-induced human myelopoiesis by transforming growth factor-beta isoforms. Cytokines Cell Mol Ther. 7(1):31-36.
    PubMed ID: 12171249
  • Mazza JJ, Yale SH. (2002 April). Influenza: prospects for control. Ann Intern Med. 136(4):338-339.
    PubMed ID: 11848732
  • Hussain K, Mazza JJ, Clouse LH. (2003 March). Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): Case report and review of the literature. Am J Hematol. 72(3):212-215.
    PubMed ID: 12605395
  • Mazza JJ. (2004 November). Aperture: Auer rods galore! Clin Med Res. 2(4):253.
    PubMed ID: 15962019
  • Musana KA, Yale SH, Mazza JJ, Reed KD. (2004 November). Practical considerations to influenza vaccination. Clin Med Res. 2(4):256-259.
    PubMed ID: 15931366
  • Mazza JJ. (2004 April). Hypercoagulability and venous thromboembolism: a review. WMJ. 103(2):41-49.
    PubMed ID: 15139558
  • Vande Zande VL, Mazza JJ, Yale SH. (2004 April). Hematologic and metabolic abnormalities in a patient with anorexia nervosa. WMJ. 103(2):38-40.
    PubMed ID: 15139557
  • Yale SH, Mazza JJ, Kieke BA. (2004). Recurrent venothromboembolism in patients with and without anti-coagulation after inferior venal caval filter placement. JOURNAL OF GENERAL INTERNAL MEDICINE. 19(S1):204.
  • Yale SH, Medlin SC, Liang H, Peters TL, Glurich IE, Mazza JJ. (2005 September). Risk assessment model for venothromboembolism in post-hospitalized patients. Int Angiol. 24(3):250-254.
    PubMed ID: 16158034
  • Mazza JJ, Yale SH, Arrowood J, Reynolds CE, Glurich IE, Chyou P,...Reed KD [including Linneman JG.] (2005 November). Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res. 3(4):214-220.
    PubMed ID: 16303886
  • Yale SH, Vasudeva SS, Mazza JJ, Rolak LA, Arrowood J, Stichert S, Stratman EJ. (2005 March). Disorders of flushing. Compr Ther. 31(1):59-71.
    PubMed ID: 15793325
  • Mazza JJ. (2005 February). Auer Rods Galore! Clin Med Res. 3(1):34.
    PubMed ID: 15962019
  • Mazza JJ. (2006). Promoting Agricultural Health and Safety: A history of the National Farm Medicine Center. Marshfield, WI: National Farm Medicine Center.
  • Yale SH, Mazza JJ. (2006). Acute chest syndrome in sickle cell disease: pathophysiologic approach to management. In: O'Malley P D (Ed.), New developments in sickle cell disease research (pp. 169-192). Hauppauge, NY: Nova Science Publishers, Inc.
  • Aslinia FM, Mazza JJ, Yale SH. (2006 September). Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 4(3):236-241.
    PubMed ID: 16988104
  • Litzow MR, Lee S, Bennett JM, Dewald GW, Gallagher RE, Jain V,...Tallman MS [including Mazza JJ.] (2006 August). A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia. Haematologica. 91(8):1105-8.
    PubMed ID: 16870552
  • Mazza JJ. (2006 November). Incidence of hematologic malignancies in agriculture. J Agromedcine. 11(2):5-7.
    PubMed ID: 17135136
  • Yale SH, Mazza JJ, Glurich IE, Peters TL, Mukesh BNanjan. (2006 March). Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement. Int Angiol. 25(1):60-66.
    PubMed ID: 16520726
  • Ahluwalia A, Mazza JJ, Yale SH. (2007 August). Extrahepatic portal hypertension following abdominal surgery. WMJ. 106(5):266-269.
  • Mazza JJ. (2007 December). Insights into Global Nutritional Anemia: Nutritional Anemia. Clinical Medicine & Research. 5(4):209.
    PubMed ID: 18367707
  • Mazza JJ, Yale SH. (2009 February). New oral anticoagulants: a brief review. WMJ. 108(1):35-9.
    PubMed ID: 19326634
  • Johnson SK, Naidu RK, Ostopowicz RC, Kumar DR, Bhupathi S, Mazza JJ, Yale SH. (2009 September). Adolf Kussmaul: distinguished clinician and medical pioneer. Clinical Medicine & Research. 7(3):107-12.
    PubMed ID: 19805799
  • Mazza JJ. (2010 April). Infectious disease and cancer. WMJ. 109(2):66-9.
    PubMed ID: 20443324
  • Kumar DR, Hanlin E, Glurich IE, Mazza JJ, Yale SH. (2010 December). Virchow’s Contribution to the Understanding of Thrombosis and Cellular Biology. Clinical Medicine & Research. 8(3-4):168-72.
    PubMed ID: 20739582
  • Ward MA, Greenwood TM, Kumar DR, Mazza JJ, Yale SH. (2010 March). Josef Brudzinski and Vladimir Mikhailovich Kernig: signs for diagnosing meningitis. Clinical Medicine & Research. 8(1):13-7.
    PubMed ID: 20305144
  • Yale SH, Jones M, Wesbrook SD, Talsness SR, Mazza JJ. (2011 June). The Emeritus Clinical-Researcher Program. WMJ. 110(3):127-31.
    PubMed ID: 21748997
  • Talsness SR, Shukla SK, Mazza JJ, Yale SH. (2011 April). Rhabdomyolysis-induced acute kidney injury secondary to Anaplasma phagocytophilum and concomitant statin use. WMJ. 110(2):82-4.
    PubMed ID: 21560563
  • Godar DA, Kumar DR, Schmelzer KM, Talsness SR, Liang H, Schmelzer JR,...Yale SH [including Mazza JJ.] (2011 February). The impact of serum glucose on clinical outcomes in patients hospitalized with community-acquired pneumonia. WMJ. 110(1):14-20.
    PubMed ID: 21473508
  • Kumar DR, Aslinia FM, Yale SH, Mazza JJ. (2011 March). Jean-Martin Charcot: the father of neurology. Clinical Medicine & Research. 9(1):46-9.
    PubMed ID: 20739583
  • Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking WG, Yale SH, Mazza JJ. (2012 October). Anti-phospholipid antibodies in patients undergoing total joint replacement surgery. Thrombosis. 2012 :142615.
    PubMed ID: 23213505
  • Kasirye Y, Talsness SR, Walters MP, Douglas-Jones JW, Resnick JM, Mazza JJ, Yale SH. (2012 January). Multilocular thymic cyst with epithelioid granulomata of unknown etiology: a radiologic and histopathologic correlation. Ann Diagn Pathol. 16(1):38-42.
    PubMed ID: 21396863
  • Mazza JJ. (2013). A Fifty Year History of Marshfield Clinic Research Foundation Marshfield, WI: Marshfield Clinic.
  • Hebbring S, Slager S, Epperla N, Mazza JJ, Ye Z, Zhou Z,...Schrodi SJ [including Vasco DA, Brilliant MH.] (2013 January). Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia. BLOOD. 121(1):237-8.
    PubMed ID: 23287625
  • Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF,...Mazza, JJ [including Caldwell MD, Schmelzer, J.] (2013 December 12). A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 369(24):2283-93.
    PubMed ID: 24251361
  • Sanfelippo MJ, Mazza JJ, Mercier RJ. (2014 December). Symptomatic factor XIII deficiency with normal urea solubility test. Clin Lab. 60 :2099-2102.
  • Epperla N, Medina-Flores R, Mazza JJ, Yale SH. (2014 December). Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy. WMJ. 113(6):242-5.
    PubMed ID: 25745699
  • Leonhard LG, Berg RL, Burmester JK, Mazza JJ, Schmelzer JR, Yale SH. (2015 March). Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures. Clinical Medicine & Research. 13(1):1-6.
    PubMed ID: 24899695
  • Burmester JK, Berg RL, Schmelzer JR, Mazza JJ, Yale SH. (2015 February). Factors that affect rate of INR decline after warfarin discontinuation. WMJ. 114(1):16-20.
    PubMed ID: 25845131
  • Epperla N, Mazza JJ, Yale SH. (2015 April). A Review of Clinical Signs Related to Ecchymosis. WMJ. 114(2):61-5.
    PubMed ID: 26756058
  • Mazza JJ. (2016 April). Water--Our Most Precious Resource. WMJ. 115(2):61.
    PubMed ID: 27197336
  • Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. (2016 December). Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ. 115(6):317-21.
  • Ye F, Bell LN, Mazza J, Lee A, Yale SH. (2016 January 1). Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients. Clin. Appl. Thromb. Hemost.. :1076029616677802.
    PubMed ID: 28301904
  • Ye F, Stalvey C, Khuddus MA, Winchester DE, Toklu HZ, Mazza JJ, Yale SH. (2017 July). A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients. J. Thromb. Thrombolysis. 44(1):94-103.
    PubMed ID: 28484939
  • Epperla N, Ye F, Idris A, Sakkalaek A, Liang H, Chyou PH,...Yale S [including Dart RA, Mazza J.] (2017 May 19). Treatment-Related Cardiovascular Outcomes in Patients with Symptomatic Subclavian Artery Stenosis. Cureus. 9(5):e1262.
    PubMed ID: 28652946
  • Bell LN, Berg RL, Schmelzer JR, Liang H, Mazza JJ, Kanth R,...Yale SH. (2017 January). Thromboembolic complications following a first isolated episode of superficial vein thrombosis: a cross-sectional retrospective study. J. Thromb. Thrombolysis. 43(1):31-37.
    PubMed ID: 27565478
  • Sayre JW, Toklu HZ, Ye F, Mazza JJ, Yale S. (2017 August 7). Case Reports, Case Series – From Clinical Practice to Evidence-Based Medicine in Graduate Medical Education. Cureus. 9(8):e1546.